(HDSN) Hudson Technologies - Overview
Stock: Refrigerants, Reclamation, Testing, Services, Efficiency
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 42.2% |
| Relative Tail Risk | -12.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.73 |
| Alpha | 17.90 |
| Character TTM | |
|---|---|
| Beta | 1.018 |
| Beta Downside | 1.070 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.91% |
| CAGR/Max DD | -0.16 |
Description: HDSN Hudson Technologies December 29, 2025
Hudson Technologies, Inc. (NASDAQ:HDSN) operates through its subsidiary to address recurring challenges in the U.S. refrigeration market, offering a portfolio that includes refrigerant and industrial gas supply, reclamation and banking services, system decontamination, and diagnostic analytics such as Chiller Chemistry and Fluid Chemistry reports. The firm also delivers SmartEnergy OPS for real-time efficiency optimization and ChillSmart, a health-monitoring tool for packaged chillers, while participating in carbon-offset projects for commercial, industrial, governmental, and OEM customers.
Key sector drivers include the EPA’s phasedown of high-global-warming-potential (GWP) refrigerants, which fuels demand for reclamation and alternative-refrigerant services-a market projected to exceed $10 billion by 2028. Hudson’s 2023 revenue grew ~12% YoY to $115 million, with a gross margin of roughly 38%, reflecting the high-value nature of its managed-services contracts. Additionally, the broader HVAC-R industry benefits from rising construction activity and increased ESG spending, both of which support higher spend on energy-efficiency solutions like SmartEnergy OPS.
For a deeper, data-driven assessment of HDSN’s valuation metrics and peer comparisons, consider exploring ValueRay’s analytical platform.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 22.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -13.02 > 1.0 |
| NWC/Revenue: 71.91% < 20% (prev 63.46%; Δ 8.46% < -1%) |
| CFO/TA 0.15 > 3% & CFO 50.1m > Net Income 22.7m |
| Net Debt (-86.2m) to EBITDA (33.0m): -2.61 < 3 |
| Current Ratio: 3.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (45.2m) vs 12m ago -4.01% < -2% |
| Gross Margin: 27.16% > 18% (prev 0.30%; Δ 2686 % > 0.5%) |
| Asset Turnover: 73.06% > 50% (prev 79.93%; Δ -6.87% > 0%) |
| Interest Coverage Ratio: 5.43 > 6 (EBITDA TTM 33.0m / Interest Expense TTM 2.02m) |
Altman Z'' 7.37
| A: 0.50 (Total Current Assets 234.4m - Total Current Liabilities 64.0m) / Total Assets 338.9m |
| B: 0.47 (Retained Earnings 159.9m / Total Assets 338.9m) |
| C: 0.03 (EBIT TTM 11.0m / Avg Total Assets 324.2m) |
| D: 2.19 (Book Value of Equity 160.4m / Total Liabilities 73.1m) |
| Altman-Z'' Score: 7.37 = AAA |
Beneish M -3.06
| DSRI: 1.08 (Receivables 29.6m/28.5m, Revenue 236.8m/247.3m) |
| GMI: 1.10 (GM 27.16% / 29.88%) |
| AQI: 0.86 (AQ_t 0.23 / AQ_t-1 0.26) |
| SGI: 0.96 (Revenue 236.8m / 247.3m) |
| TATA: -0.08 (NI 22.7m - CFO 50.1m) / TA 338.9m) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of HDSN shares?
Over the past week, the price has changed by +3.35%, over one month by +6.16%, over three months by +10.60% and over the past year by +31.15%.
Is HDSN a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HDSN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.6 | 30% |
| Analysts Target Price | 9.6 | 30% |
| ValueRay Target Price | 7.4 | -0.4% |
HDSN Fundamental Data Overview February 03, 2026
P/E Forward = 17.5131
P/S = 1.3198
P/B = 1.1612
P/EG = 0.2942
Revenue TTM = 236.8m USD
EBIT TTM = 11.0m USD
EBITDA TTM = 33.0m USD
Long Term Debt = 5.54m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.96m USD (from shortTermDebt, last fiscal year)
Debt = 3.49m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -86.2m USD (from netDebt column, last quarter)
Enterprise Value = 226.4m USD (312.6m + Debt 3.49m - CCE 89.7m)
Interest Coverage Ratio = 5.43 (Ebit TTM 11.0m / Interest Expense TTM 2.02m)
EV/FCF = 5.08x (Enterprise Value 226.4m / FCF TTM 44.6m)
FCF Yield = 19.70% (FCF TTM 44.6m / Enterprise Value 226.4m)
FCF Margin = 18.83% (FCF TTM 44.6m / Revenue TTM 236.8m)
Net Margin = 9.60% (Net Income TTM 22.7m / Revenue TTM 236.8m)
Gross Margin = 27.16% ((Revenue TTM 236.8m - Cost of Revenue TTM 172.5m) / Revenue TTM)
Gross Margin QoQ = 31.99% (prev 31.31%)
Tobins Q-Ratio = 0.67 (Enterprise Value 226.4m / Total Assets 338.9m)
Interest Expense / Debt = 22.71% (Interest Expense 792.0k / Debt 3.49m)
Taxrate = 24.36% (3.99m / 16.4m)
NOPAT = 8.29m (EBIT 11.0m * (1 - 24.36%))
Current Ratio = 3.66 (Total Current Assets 234.4m / Total Current Liabilities 64.0m)
Debt / Equity = 0.01 (Debt 3.49m / totalStockholderEquity, last quarter 265.9m)
Debt / EBITDA = -2.61 (Net Debt -86.2m / EBITDA 33.0m)
Debt / FCF = -1.93 (Net Debt -86.2m / FCF TTM 44.6m)
Total Stockholder Equity = 253.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.01% (Net Income 22.7m / Total Assets 338.9m)
RoE = 8.97% (Net Income TTM 22.7m / Total Stockholder Equity 253.3m)
RoCE = 4.23% (EBIT 11.0m / Capital Employed (Equity 253.3m + L.T.Debt 5.54m))
RoIC = 3.27% (NOPAT 8.29m / Invested Capital 253.3m)
WACC = 9.75% (E(312.6m)/V(316.1m) * Re(9.67%) + D(3.49m)/V(316.1m) * Rd(22.71%) * (1-Tc(0.24)))
Discount Rate = 9.67% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.35%
[DCF Debug] Terminal Value 72.93% ; FCFF base≈59.2m ; Y1≈62.6m ; Y5≈74.4m
Fair Price DCF = 24.36 (EV 961.5m - Net Debt -86.2m = Equity 1.05b / Shares 43.0m; r=9.75% [WACC]; 5y FCF grow 6.49% → 2.90% )
EPS Correlation: -73.25 | EPS CAGR: -43.89% | SUE: 1.71 | # QB: 4
Revenue Correlation: -13.62 | Revenue CAGR: 19.64% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.11 | Chg30d=-0.040 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.45 | Chg30d=-0.110 | Revisions Net=+1 | Growth EPS=-5.3% | Growth Revenue=+3.0%